Improve Endometriosis Diagnostics with the NIH RADx® Tech ACT ENDO Challenge!
VirtualWe are excited to announce the launch of the NIH RADx® Tech ACT ENDO Challenge.This initiative aims to accelerate the development of innovative technologies for diagnosing endometriosis, a chronic condition that urgently requires better diagnostic tools. The ACT ENDO Challenge is calling on innovators to develop cutting-edge solutions that will: Shorten diagnosis time Eliminate the invasiveness of current diagnostic techniques Improve accessibility, safety, convenience, and costs Potential technologies include advanced imaging, in vitro diagnostic devices, smartphone-enabled tools, wearable devices, integrated sensing technologies, and digital health platforms. This two-year challenge will consist of three phases. Submissions to Phase I are due October 11, 2024, and final winners are expected to be announced in March 2026. The first-place winner can earn up to $950,000, the second-place winner can earn $850,000, the third-place winner can earn $750,000, and the runner-up can earn $450,000. An informational webinar is scheduled for August 28, 2024, from 11AM to 12PM ET. You can register here. Learn more about how you can participate in the RADx® Tech ACT ENDO Challenge and make a difference in women's health: https://www.challenge.gov/?challenge=radx-tech-act-endo.
Time Management, Identifying Success Barriers, and Dealing with Administrators
VirtualNIRF workshops are all virtual, All run from 2-5pm, with 4-5pm set aside for Q&A. This online seminar, is scheduled for September 13th, 2024. Managing academic life is a struggle at every career stage. Join us for frank discussions about creating space to have the time you need to accomplish your goals by first identifying the barriers to your success. We will also discuss strategies for managing the academic administrators that can represent a barrier or a solution. This professional development workshop is open to any faculty at any NM-INBRE institution. Registration is required.
FDA/NIH Joint Workshop: Developing Implanted Brain-Computer Interface Clinical Outcome Assessments to Demonstrate Benefit
HybridHybrid workshop held on FDA campus 9/19-9/20; webcast available The Food and Drug Administration (FDA) and National Institutes of Health (NIH) are announcing a public workshop to engage with stakeholders in the implanted brain-computer interface device ecosystem. The purpose of this public workshop is to discuss implanted brain-computer interface devices and to hear from stakeholders about the development of clinical outcome assessments to evaluate the effectiveness of implanted brain-computer interfaces. Workshop Date: Thursday, September 19 and Friday, September 20, 2024 Location: Hybrid: The FDA’s White Oak Campus in Silver Spring, MD and webcast Registration Deadline: September 12, 2024 See the preliminary agenda and register for the meeting here. If you have questions about this public workshop, please contact: CDRH_BCI_Workshop2024@fda.hhs.gov.